Tauchi T - Search Results

1

[Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].

Tanaka Y, Ito Y, Yoshizawa S, Fujimoto H, Gotoh M, Tauchi T, Kimura Y, Ohyashiki K. Tanaka Y, et al. Among authors: tauchi t. Rinsho Ketsueki. 2013 Feb;54(2):229-31. Rinsho Ketsueki. 2013. PMID: 23470833 Japanese.

2

[Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].

Sumi M, Tauchi T, Shimamoto T, Sshida G, Nakajima A, Ito Y, Ohyashiki K. Sumi M, et al. Among authors: tauchi t. Rinsho Ketsueki. 2002 Sep;43(9):868-70. Rinsho Ketsueki. 2002. PMID: 12412295 Japanese.

3

[Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera].

Sumi M, Tauchi T, Takaku T, Ohyashiki JH, Ohyashiki K. Sumi M, et al. Among authors: tauchi t. Rinsho Ketsueki. 2005 Nov;46(11):1208-12. Rinsho Ketsueki. 2005. PMID: 16440805 Japanese.

4

[New horizon of chronic myelogenous leukemia].

Tauchi T, Ohyashiki K. Tauchi T, et al. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:75-9. Nihon Rinsho. 2007. PMID: 17474396 Review. Japanese. No abstract available.

5

[New horizon of chronic myelogenous leukemia].

Tauchi T, Ohyashiki K. Tauchi T, et al. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:617-21. Nihon Rinsho. 2007. PMID: 17474470 Review. Japanese. No abstract available.

6

[Molecular relapse of chronic myeloid leukemia after discontinuation of imatinib mesylate for maintaining complete molecular response for more than 2 years].

Kiguchi T, Tauchi T, Ohyashiki K. Kiguchi T, et al. Among authors: tauchi t. Rinsho Ketsueki. 2009 Jan;50(1):52-4. Rinsho Ketsueki. 2009. PMID: 19225231 Japanese.

7

Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvement.

YOSHIZAWA S, AKAHANE D, FUJIMOTO H, GOTOH M, KIGUCHI T, TAUCHI T, OHYASHIKI K. YOSHIZAWA S, et al. Among authors: tauchi t. Rinsho Ketsueki. 2009 Nov;50(11):1647-51. Rinsho Ketsueki. 2009. PMID: 20009442

8

[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib].

Katagiri S, Tauchi T, Umezu T, Saito Y, Suguro T, Asano M, Yoshizawa S, Kitahara T, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Ito Y, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: tauchi t. Rinsho Ketsueki. 2015 Feb;56(2):216-9. doi: 10.11406/rinketsu.56.216. Rinsho Ketsueki. 2015. PMID: 25765803 Japanese.

9

[Musculoskeletal pain after stopping tyrosine kinase inhibitor in patients with chronic myeloid leukemia: a questionnaire survey].

Katagiri S, Tauchi T, Saito Y, Suguro T, Asano M, Yoshizawa S, Sakuta J, Akahane D, Tanaka Y, Furuya N, Ando K, Fujimoto H, Okabe S, Gotoh M, Ito Y, Ohyashiki K. Katagiri S, et al. Among authors: tauchi t. Rinsho Ketsueki. 2016 Jul;57(7):873-6. doi: 10.11406/rinketsu.57.873. Rinsho Ketsueki. 2016. PMID: 27498732 Japanese.

10

[BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation].

Amemiya A, Ito Y, Ishibashi Y, Saito Y, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Tauchi T, Ohyashiki K. Amemiya A, et al. Among authors: tauchi t. Rinsho Ketsueki. 2017;58(4):298-302. doi: 10.11406/rinketsu.58.298. Rinsho Ketsueki. 2017. PMID: 28484156 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters